Validation and Application of Long-Read Whole-Genome Sequencing for Antimicrobial Resistance Gene Detection and Antimicrobial Susceptibility Testing.


Journal

Antimicrobial agents and chemotherapy
ISSN: 1098-6596
Titre abrégé: Antimicrob Agents Chemother
Pays: United States
ID NLM: 0315061

Informations de publication

Date de publication:
24 01 2023
Historique:
pubmed: 20 12 2022
medline: 27 1 2023
entrez: 19 12 2022
Statut: ppublish

Résumé

Next-generation sequencing applications are increasingly used for detection and characterization of antimicrobial-resistant pathogens in clinical settings. Oxford Nanopore Technologies (ONT) sequencing offers advantages for clinical use compared with other sequencing methodologies because it enables real-time basecalling, produces long sequencing reads that increase the ability to correctly assemble DNA fragments, provides short turnaround times, and requires relatively uncomplicated sample preparation. A drawback of ONT sequencing, however, is its lower per-read accuracy than short-read sequencing. We sought to identify best practices in ONT sequencing protocols. As some variability in sequencing results may be introduced by the DNA extraction methodology, we tested three DNA extraction kits across three independent laboratories using a representative set of six bacterial isolates to investigate accuracy and reproducibility of ONT technology. All DNA extraction techniques showed comparable performance; however, the DNeasy PowerSoil Pro kit had the highest sequencing yield. This kit was subsequently applied to 42 sequentially collected bacterial isolates from blood cultures to assess Ares Genetics's pipelines for predictive whole-genome sequencing antimicrobial susceptibility testing (WGS-AST) performance compared to phenotypic triplicate broth microdilution results. WGS-AST results ranged across the organisms and resulted in an overall categorical agreement of 95% for penicillins, 82.4% for cephalosporins, 76.7% for carbapenems, 86.9% for fluoroquinolones, and 96.2% for aminoglycosides. Very major errors/major errors were 0%/16.7% (penicillins), 11.7%/3.6% (cephalosporins), 0%/24.4% (carbapenems), 2.5%/7.7% (fluoroquinolones), and 0%/4.1% (aminoglycosides), respectively. This work showed that, although additional refinements are necessary, ONT sequencing demonstrates potential as a method to perform WGS-AST on cultured isolates for patient care.

Identifiants

pubmed: 36533931
doi: 10.1128/aac.01072-22
pmc: PMC9872642
doi:

Substances chimiques

Anti-Bacterial Agents 0
Carbapenems 0
Fluoroquinolones 0
Cephalosporins 0
Penicillins 0
Aminoglycosides 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e0107222

Références

Antimicrob Agents Chemother. 2019 Dec 20;64(1):
pubmed: 31611361
Food Microbiol. 2020 Aug;89:103452
pubmed: 32138998
PLoS One. 2021 Oct 1;16(10):e0257521
pubmed: 34597327
J Antimicrob Chemother. 2017 Jan;72(1):104-114
pubmed: 27667325
Nat Methods. 2022 Jul;19(7):823-826
pubmed: 35789207
J Clin Microbiol. 2021 Nov 18;59(12):e0013521
pubmed: 34076468
Nat Methods. 2015 Apr;12(4):351-6
pubmed: 25686389
Genome Res. 2017 May;27(5):737-746
pubmed: 28100585
Mol Biol Evol. 2021 Sep 27;38(10):4647-4654
pubmed: 34320186
Genome Biol. 2014 Dec 17;15(12):564
pubmed: 25608874
Genome Res. 2017 May;27(5):722-736
pubmed: 28298431
J Clin Microbiol. 2020 Jun 24;58(7):
pubmed: 32295890
Bioinformatics. 2009 Aug 15;25(16):2078-9
pubmed: 19505943
BMC Biol. 2014 Nov 12;12:87
pubmed: 25387460
Antimicrob Agents Chemother. 2018 Dec 21;63(1):
pubmed: 30373801
Front Microbiol. 2020 Aug 05;11:1883
pubmed: 32849463
Nat Biotechnol. 2021 Nov;39(11):1348-1365
pubmed: 34750572
Microb Genom. 2018 Mar;4(3):
pubmed: 29543149
Gut Pathog. 2016 May 26;8:24
pubmed: 27239228
Genome Med. 2015 Sep 29;7:99
pubmed: 26416663
Nat Biotechnol. 2019 Jul;37(7):783-792
pubmed: 31235920
Bioinformatics. 2018 Aug 1;34(15):2666-2669
pubmed: 29547981
J Clin Microbiol. 2017 Aug;55(8):2502-2520
pubmed: 28592550
Antimicrob Agents Chemother. 2014 Jul;58(7):3895-903
pubmed: 24777092
Bioinformatics. 2013 Apr 15;29(8):1072-5
pubmed: 23422339
Nature. 2016 Feb 11;530(7589):228-232
pubmed: 26840485
Lancet. 2018 May 19;391(10134):1976-1978
pubmed: 29864011
Nat Methods. 2015 Jan;12(1):59-60
pubmed: 25402007
Int J Mol Sci. 2021 Dec 02;22(23):
pubmed: 34884852
Microb Genom. 2021 Nov;7(11):
pubmed: 34825880
PLoS One. 2019 Jul 30;14(7):e0220494
pubmed: 31361781
Bioinformatics. 2010 Mar 15;26(6):841-2
pubmed: 20110278
Genome Biol. 2019 Nov 28;20(1):257
pubmed: 31779668
J Clin Microbiol. 2016 Aug;54(8):1975-83
pubmed: 27008877
Bioinformatics. 2014 Jul 15;30(14):2068-9
pubmed: 24642063
Clin Microbiol Infect. 2004 Nov;10 Suppl 4:1-9
pubmed: 15522034
Front Cell Infect Microbiol. 2021 Feb 15;11:610348
pubmed: 33659219

Auteurs

Thomas Weinmaier (T)

Ares Genetics GmbH, Vienna, Austria.

Rick Conzemius (R)

Ares Genetics GmbH, Vienna, Austria.

Yehudit Bergman (Y)

Department of Pathology, Johns Hopkins University School of Medicinegrid.471401.7, Baltimore, Maryland, USA.

Shawna Lewis (S)

Department of Pathology, Johns Hopkins University School of Medicinegrid.471401.7, Baltimore, Maryland, USA.

Emily B Jacobs (EB)

Department of Pathology, Johns Hopkins University School of Medicinegrid.471401.7, Baltimore, Maryland, USA.

Pranita D Tamma (PD)

Department of Pediatrics, Division of Infectious Diseases, Johns Hopkins University School of Medicinegrid.471401.7, Baltimore, Maryland, USA.

Arne Materna (A)

Ares Genetics GmbH, Vienna, Austria.

Johannes Weinberger (J)

Ares Genetics GmbH, Vienna, Austria.

Stephan Beisken (S)

Ares Genetics GmbH, Vienna, Austria.

Patricia J Simner (PJ)

Department of Pathology, Johns Hopkins University School of Medicinegrid.471401.7, Baltimore, Maryland, USA.

Articles similaires

Genome, Chloroplast Phylogeny Genetic Markers Base Composition High-Throughput Nucleotide Sequencing

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C

Classifications MeSH